Literature DB >> 2680870

Primary malignant lymphoma of the large intestine complicating chronic inflammatory bowel disease.

N A Shepherd1, P A Hall, G T Williams, B W Codling, E L Jones, D A Levison, B C Morson.   

Abstract

Ten cases of malignant lymphoma of the colon and rectum complicating chronic inflammatory bowel disease are presented. Seven patients had chronic ulcerative colitis with a history varying from 6 to 20 years. There was extensive colitis in six of these patients and left-sided colitis in one. All seven lymphomas showed the pathological and immunohistological features of primary B-cell tumours of the gastrointestinal tract with a predominance of high-grade tumours. Three patients had Crohn's disease of the large intestine complicated by malignant lymphoma of the sigmoid colon or rectum. The history of Crohn's disease varied from 30 months to 20 years and in each case there was fissuring and fistulae. There was extensive anal involvement in two cases. Histologically the three lymphomas were heterogeneous: one was of 'granulomatous' T-cell type and the other two were markedly polymorphic and of equivocal phenotype. They were also characterized by numerous multinucleate tumour giant cells. Primary colorectal malignant lymphoma should be regarded as a rare, but significant, complication of ulcerative colitis. Immunosuppression may be an additional factor in the genesis of intestinal lymphoma in Crohn's disease. The prognosis appears to be dependent on factors already known to be of prognostic significance in primary gut lymphomas: a predominance of high-grade tumours suggests that the outlook is generally worse than that for idiopathic primary large intestinal lymphoma.

Entities:  

Mesh:

Year:  1989        PMID: 2680870     DOI: 10.1111/j.1365-2559.1989.tb01585.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  10 in total

1.  Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low.

Authors:  R J Farrell; Y Ang; P Kileen; D S O'Briain; D Kelleher; P W Keeling; D G Weir
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

2.  An unusual case of fever and a sigmoid mass.

Authors:  Tamara Kubba; Mio Takatsuka; Eve Stern; Thomas Smith; Jason Lee; Maitham Al-Whouhayb; Michael Saunders
Journal:  BMJ Case Rep       Date:  2011-03-29

3.  A steroid-refractory ulcerative colitis revealing Epstein-Barr virus/cytomegalovirus-positive colonic lymphoma.

Authors:  Fady Daniel; Diane Damotte; Henri Moindrot; Thierry Molina; Anne Berger; Christophe Cellier
Journal:  Int J Colorectal Dis       Date:  2005-03-04       Impact factor: 2.571

Review 4.  Pathological mimics of chronic inflammatory bowel disease.

Authors:  N A Shepherd
Journal:  J Clin Pathol       Date:  1991-09       Impact factor: 3.411

5.  Primary colon lymphoma in Korea: a KASID (Korean Association for the Study of Intestinal Diseases) Study.

Authors:  Y-H Kim; J H Lee; S K Yang; T I Kim; J S Kim; H J Kim; J I Kim; S W Kim; J O Kim; I K Jung; S A Jung; M K Jung; H S Kim; S J Myung; W H Kim; J C Rhee; K Y Choi; I S Song; J H Hyun; Y I Min
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

6.  Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease.

Authors:  T Spieker; H Herbst
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

7.  T cell lymphoproliferative disorders associated with anti-tumor necrosis factor alpha antibody therapy for ulcerative colitis: literature summary.

Authors:  Lindsay A Schmidt; Megan S Lim
Journal:  J Hematop       Date:  2009-03-18       Impact factor: 0.196

8.  Metachronous colonic lymphomas complicating chronic ulcerative colitis.

Authors:  D H Hill; J O Mills; R J Maxwell
Journal:  Abdom Imaging       Date:  1993

Review 9.  Colitis ulcerosa complicated by malignant lymphoma: case report and analysis of published works.

Authors:  R Lenzen; F Borchard; H Lübke; G Strohmeyer
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

10.  Rectal lymphoma after colectomy for ulcerative colitis.

Authors:  J P Teare; S M Greenfield; S Slater
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.